These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1963179)

  • 21. Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal.
    Coursaget P; Leboulleux D; Le Cann P; Bao O; Coll-Seck AM
    Trans R Soc Trop Med Hyg; 1992; 86(5):552-3. PubMed ID: 1282278
    [No Abstract]   [Full Text] [Related]  

  • 22. [The etiology of liver cirrhosis and the clinical analysis of anti-HCV positive patients with liver cirrhosis].
    Yoshida T; Sato S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):685-9. PubMed ID: 7563857
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus infection in chronic liver disease in Natal.
    Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
    S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the -844C > T polymorphism in the promoter region of FASLgene in a cohort of Spanish HCV patients.
    Ruiz-Ferrer M; Antiñolo G; Aguilar-Reina J
    J Viral Hepat; 2007 Apr; 14(4):293-4. PubMed ID: 17381722
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
    Barnes RE; Meyer RA; Gordon SC
    Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical course and prognostic value of Child-Turcotte criteria and Child-Pugh score in medically treated cirrhosis positive for HCV antibody--in comparison with cirrhosis positive for HBs Ag].
    Shibata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):711-9. PubMed ID: 7563862
    [No Abstract]   [Full Text] [Related]  

  • 27. Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis.
    Tseng KC; Lin MN; Chu TY; Tsai JP; Su CC
    Emerg Microbes Infect; 2017 Jun; 6(6):e45. PubMed ID: 28588294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of hepatitis C virus antibodies among high risk groups in Thailand.
    Poovorawan Y; Pongpunlert W; Chumdermpadetsuk S; Sakulramrung R; Israsena S
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):133-4. PubMed ID: 1658945
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevalence of the antibody of hepatitis C virus in HBsAg negative patients with chronic liver diseases: children, prostitutes, and homosexuals].
    Vetencourt R; de Armas J; Vetencourt M
    G E N; 1990; 44(4):349-52. PubMed ID: 1967088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV genotype 3: a wolf in sheep's clothing.
    Blanco JR; Rivero-Juarez A
    Expert Rev Anti Infect Ther; 2016; 14(2):149-52. PubMed ID: 26635242
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus in patients with positive HBsAg.
    Gargot D; Ducreux M; Dussaix E; Pelletier G; Briantais MJ; Yvart J; Buffet C
    Dig Dis Sci; 1990 Nov; 35(11):1437-8. PubMed ID: 2171886
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment, and prevention. Report of a meeting of Physicians and Scientists.
    Lancet; 1995 Mar; 345(8949):562-6. PubMed ID: 7776777
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
    Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C in liver transplant recipients.
    Read AE; Donegan E; Lake J; Ferrell L; Galbraith C; Kuramoto IK; Zeldis JB; Ascher NL; Roberts J; Wright TL
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1504-5. PubMed ID: 1846471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients.
    Gupta S; Singh S
    World J Gastroenterol; 2006 Nov; 12(42):6879-83. PubMed ID: 17106941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases.
    Inoue Y; Suzuki R; Matsuura Y; Harada S; Chiba J; Watanabe Y; Saito I; Miyamura T
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2151-4. PubMed ID: 1379627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-hepatitis C viral antibodies in different pathological entities in Chile].
    Velasco M; Hurtado C; Brahm J
    Rev Med Chil; 1990 Aug; 118(8):895-6. PubMed ID: 1967082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cirrhosis and membranoproliferative glomerulonephritis caused by inapparent hepatitis C virus infection.
    Kalinski T; Klante T; Päge I; Schneider-Stock R; Dombrowski F; Roessner A
    Pathol Res Pract; 2006; 202(12):891-4. PubMed ID: 17092658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of cytomegalovirus coinfection in HCV-infected patients with late liver fibrosis is associated with dysregulation of JAK-STAT pathway.
    Ibrahim MK; Khedr A; Bader El Din NG; Khairy A; El Awady MK
    Sci Rep; 2017 Sep; 7(1):10364. PubMed ID: 28871140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.